This site uses cookies. By using this site you agree to receiving cookies. View Policy.

102%
Raised
£308,910
Investors
370
Target
£300,000
Equity
13.38%
Pre-money valuation
£2,000,000

Techstars alumni drfocused are building the Doctors' Digital Back Office. As featured in WIRED Health, their software has been used in over 74 UK hospitals. Rostering software contracts are worth up to £800k per trust. Their experienced advisory team have delivered national level health IT contracts

  • 9.4bn allocated by UK Gov. to fully digitize NHS
  • Their ‘proof of concept’ software was used in over 74 UK hospitals
  • Staffing is the biggest cost in healthcare but remains inefficient
  • Team includes experienced healthcare professionals and advisors

Idea

Doctors currently spend 30% of their time entering data instead of treating patients. This increases costs for hospitals, takes time away from patients and contributes to burnout in doctors.

Product

We make software designed to help doctors complete their work faster than present alternatives, with our current focus on rostering.

We are building the Doctors’ Digital Back Office. Our first product is cloud-based HR SaaS for medical admin/rostering. It allows doctors and hospitals to complete admin paperwork, communicate securely, and organise clinical work from a phone/tablet. We provide insights to clinical managers using predictive data analytics to improve patient safety and clinical efficiency.

Our nearly 1000-strong community help to test, prototype and build our software.

Traction

As a team, we were selected as one of 11 teams from 1,100+ applicants to participate in the 2016 Techstars London accelerator, gaining coverage in TechCrunch. We've also had projects win the UCL Bright Ideas Award.

We completed and launched our app with users across 74 hospitals, have received positive feedback from medical professionals, and we showcased at WIRED Health.

After demonstrating our development and user acquisition capability with our app, we have been asked by several organisations, such as Health Education England and the Whittington Hospital, to work with them to develop further systems.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

To see the rest of the drfocused pitch, join now. It's free, quick and easy.

Due to financial regulations, you need to join our community to view the full investment opportunity.

Join

Already registered?
Log in

Risk warning

Investments of this nature carry risks to your capital, including illiquidity, lack of dividends and dilution. Balance risk with a diversified portfolio. Read more. Approved as a financial promotion by Crowdcube Capital Limited, which is authorised and regulated by the Financial Conduct Authority.

Investment opportunities are not offers to the public and investors must be eligible Crowdcube members. Further restrictions and Crowdcube's limitation of liability are set out in the Investor Terms and Conditions. Please seek independent advice as required as Crowdcube does not give investment or tax advice.

drfocused has been given advance assurance by HMRC that the proposed share issue is likely to qualify for Enterprise Investment Scheme (EIS) tax relief.

Tax relief is available to individuals only, with income tax relief currently set at 30 per cent of the cost of the shares for the tax year in which the investment was made. The tax reliefs can also reduce your Capital Gains Tax bill. Read More.

Availability of tax relief depends on your individual and the company’s ongoing circumstances and applicable law.